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Analgesic intolerance (AI) which is classically known as a disease of the middle-aged
adults, not uncommonly starts in childhood. In this study we sought to identify the
characteristics of childhood onset AI and evaluated its association with the development of
asthma. Among 729 analgesic intolerant patients followed in our institution between
January 1991 and July 2004, 50 (16 male, 34 female, 6.8% of the total AI population) had
history of AI starting before the age of 18. The prevalence of asthma was 24% in childhood
and increased to 40% during adulthood. Atopy was more common in patients with bronchial
asthma (po0.05). The mean (7SD) age of onset for asthma (18.679.7 years) was
signiﬁcantly greater than the onset of both rhinitis and AI (13.076.5 and 13.274.0 years,
respectively). This ﬁnding is different than the chronology of events reported in the
literature for adult onset AI patients, in which rhinitis and asthma usually precede the
development of AI. The presence of such a difference in the sequence of disease patterns
may be a clue for the pathophysiologic differences underlying childhood and adult onset
AI. The role of childhood onset AI as a risk factor for developing for asthma in adulthood
should be further assessed in prospective patient cohorts.
& 2008 Elsevier Ltd. All rights reserved.Introduction
Non-steroidal anti-inﬂammatory drugs (NSAIDs), including
aspirin (acetyl salicylic acid—ASA), are among the most
frequently prescribed medications worldwide. Hypersensi-Elsevier Ltd. All rights reserved.
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).tivity to these agents is one of the most important allergic
drug reactions, with an estimated prevalence of 1% in the
general population and 10–20% in patients with asthma.1–5
Analgesic intolerance (AI) has been widely studied in the
adult population and to a lesser extent in children. The
prevalence of NSAID-induced asthma in children is around 5%
with oral provocation tests (OPTs), whereas decrease in
pulmonary functions range up to 28% in asthmatic chil-
dren.6,7 Adults with AI usually have either severe asthma
with chronic sinusitis or chronic urticaria and the ﬁrst
reaction to NSAIDs generally occurs several years after the
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was to ﬁnd out the characteristics of childhood onset AI and
to evaluate whether it’s a risk factor for adulthood asthma.
Methods
The records of patients diagnosed with AI in our adult allergy
unit between 1 January 1991 and 31 July 2004 were
analyzed retrospectively. AI was deﬁned by the presence
of clinical history for at least two episodes of any of the
following reactions within 20–180min after aspirin or NSAID
ingestion: angioedema, acute urticaria, nasal obstruction,
rhinitis, bronchospasm or anaphylaxis. Patients reporting
the ﬁrst episode of reaction to NSAIDs before the age of 18
were accepted as having childhood onset AI and included
into the study. The following information was obtained for
all patients: age, gender, smoking history, past medical
history, the presence of asthma, rhinitis and nasal polyposis
and the duration of these diseases, characteristics of AI (age
of onset, causative analgesic/analgesics, reaction type),
accompanying allergic diseases (atopy, antibiotic allergy,
metal allergy, dermographism), emergency department
visits due to AI reactions, and familial history for atopy,
asthma and AI. Atopy, which was deﬁned as at least one
positive reaction to any of the 16 common aeroallergens
(Dermatophagoides pteronyssinus, Phleum pratense, Olea
europaea, Artemisia vulgaris, Parietaria ofﬁcinalis, Corylus
avellana, Betula verrucosa, cat, dog, horse, Alternaria
alternata, Cladosporium herbarum, Aspergillus fumigatus,
cockroach, Apis mellifera, Vespula) in skin prick tests (SPT;Table 1 Characteristics of patients with childhood onset analg
Bronchial asthma (
N 20
Male 6 (30.0)
Smoking history 2 (10.0)
Familial atopy history 5 (25.0)
Familial asthma history 9 (45.0)
Familial AI history 9 (45.0)
Metal allergy 5 (25.0)
Antibiotic allergy 4 (20.0)
Dermographism 3 (15.0)
Atopy (SPT positivity/SPT performed) 7/13 (53.8)
Rhinitis 17 (85.0)
Nasal polyposis 4 (20.0)
AI
Aspirin 15 (85.0)
Other NSAIDs 5 (15.0)
Reactions
Respiratory
Bronchospasm 12 (60.0)
Nasal obstruction/rhinitis 5 (25.0)
Dermatologic
Acute urticaria 8 (40.0)
Angioedema 9 (45.0)
SPT: skin prick tests; AI: analgesic intolerance; NSAID: non-steroidal
po0.05.ALK-Denmark, Stallergens-France and Greer-USA), was
assessed in 32 patients. SPT could not be performed in the
remaining 18 patients due to the presence of dermograph-
ism, acute urticaria and/or the need for antihistaminic
treatment at the time of evaluation. The study population
was divided into two groups according to the presence or
absence of ever diagnosis of bronchial asthma.
All numerical values in the text are expressed as
mean7standard deviation (SD). Mann–Whitney U test and
Wilcoxon signed rank test were used for comparison of
numeric variables. Differences between categorical vari-
ables were compared by chi square or Fisher’s exact test. A
p value of o0.05 was considered signiﬁcant. Statistical
analysis was done by SPSS version 10.0.
Results
Out of 729 patients with the diagnosis of AI, 50 (6.8%; 34
females–16 males; female/male ratio: 2.1) had childhood
onset AI. The mean (7SD) age at the time of ﬁrst admission
to our clinic because of any allergic complaint was 25.079.4
(range 16–56) years. Baseline patient characteristics are
shown in Table 1.
Twenty-four patients (48%) had a diagnosis of rhinitis on
admission among which 22 had rhinitis starting during
childhood period. The mean age of onset for rhinitis was
13.076.5 (range 2–31) years. The diagnosis of nasal
polyposis, conﬁrmed by an ear–nose–throat (ENT) specialist,
was established in ﬁve patients and four of these patients
underwent polypectomy procedures due to nasal obstruction.esic intolerance.
+) n (%) Bronchial asthma () n (%) Total n (%)
30 50
10 (33.3) 16 (32.0)
11 (33.6) 13 (26.0)
5 (16.6) 10 (20.0)
3 (10.0) 12 (24.0)
8 (26.6) 17 (34.0)
6 (20.0) 11 (22.0)
10 (33.3) 14 (28.0)
4 (13.4) 7 (14.0)
3/19 (15.7) 10/32 (31.2)
7 (23.3) 24 (48.0)
1 (3.3) 5 (10.0)
19 (63.3) 34 (68.0)
11 (36.6) 16 (32.0)
1 (3.3) 13 (26.0)
1 (3.3) 6 (12.0)
22 (73.3) 30 (60.0)
23 (76.7) 32 (64.0)
anti-inﬂammatory drug.
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diagnosis of asthma, whereas asthma was present in only 11%
of the patients without rhinitis.
Overall 20 patients (40%) had a diagnosis of asthma. The
diagnosis was established during childhood (p18 years of
age) in 12 patients (24%) and during adulthood (418 years of
age) in eight patients (16%). The incidence of asthma was
21% during adulthood (8 out of 38 patients without prior
diagnosis of asthma). There was no statistical difference
regarding the incidence rates before (24%) and after 18
years (21%). The mean age of onset for asthma was
18.679.7 (range 5–40) years; it was found to be lower in
males than females (14.379.5 and 20.579.5 years,
respectively, po0.05). The mean age of onset for asthma
was signiﬁcantly later with respect to both the mean age of
onsets for rhinitis and AI (po0.01) (Figure 1). As expected,
the frequency of rhinitis was higher in the asthmatic
group (85% vs 23%, po0.01). Among patients who were
evaluated by SPT, atopy was more common in patients
with bronchial asthma when compared to patients without
asthma (po0.05).
According to clinical history, 68% of patients were
intolerant to aspirin and the remaining were intolerant to
other NSAIDs (metamizole: 8%; paracetamol: 6%, more than
one NSAID: 18%). The mean age of onset for AI was 13.274.0
(range 3–18) years. The most common reported reactions
triggered by NSAIDs were angioedema (64%) appearing as
periorbital edema in 34% of patients; acute urticaria (60%),
bronchospasm (26%), and nasal obstruction and rhinitis
(12%). Bronchospasm and nasal obstruction/rhinitis were
signiﬁcantly more common in the asthmatic group (po0.01
and po0.05, respectively), whereas acute urticaria and
angioedema were signiﬁcantly more common (po0.05 for
both of the symptoms) in patients without asthma. Seven-
teen patients (34%) had to visit emergency department due
to AI reaction; angioedema (n ¼ 6), acute urticaria (n ¼ 2),30
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Figure 1 Age of onset of AI and asthma in childhood onset
analgesic intolerance.bronchospasm (n ¼ 2) and combinations of these symptoms
(n ¼ 7).
OPTwere performed in order to ﬁnd out a safe alternative
NSAID in 32 patients and due to presence of insufﬁcient or
suspicious history in two cases. Nine patients had positive
reactions in OPT: two with ASA, ﬁve with meloxicam, one
with nimesulid and one with piroxicam.Discussion
NSAIDs are effective for the treatment of a wide spectrum
of diseases and their widespread use contributes to the
high incidence of AI. In a recent review, the prevalence
of aspirin induced asthma determined by OPT was reported
as 21% in adults and 5% in children.6 Our study was
undertaken to determine the characteristics of early onset
AI by a retrospective analysis of patients diagnosed
as analgesic intolerant in a tertiary adult allergy clinic.
Among all the patients with AI, 6.8% had childhood onset
AI and about two thirds of these patients were women,
which was consistent with the reports in the previous
literature.2,5,8
One of the most important results obtained from this
study was the signiﬁcant difference between the mean onset
ages of AI, rhinitis and asthma. AI and rhinitis preceded the
onset of asthma by approximately ﬁve years. This ﬁnding is
different than the chronology of events reported in the
literature for adult onset analgesic intolerant asthma (AIA),
in which AI develops after rhinitis and asthma.2,3,5,8
Whether this disparity in the chronology of events repre-
sents a difference in the underlying pathophysiology of adult
and childhood onset AI is subject to further studies.
The mean age of onset for asthma was signiﬁcantly lower
in males compared to females. This ﬁnding may just be a
reﬂection of the fact that childhood asthma occurs more
commonly in males or may be secondary to different disease
progression that may be observed between genders under
the inﬂuence of female sex hormones.5,9
Although SPT was not performed in every patient, atopy
was more common in patients with asthma. Atopy is a well-
known risk factor for asthma. Previous studies have shown
that rhinitis and asthma might manifest as AIA in earlier age
in patients with atopy.5 This interplay between atopy,
asthma and AIA, might contribute to the predisposition of
atopic AI patients to develop asthma earlier in life.
Studies about AI in children are limited in number and
usually retrospective or cross-sectional in the literature. In
our study due to retrospective analysis of cases, the
diagnosis of AI was done primarily by clinical history. Based
on the clinical features AI can be subdivided into two
main groups: asthmatic and/or rhinitic (respiratory),
urticaria/angioneurotic edema (dermatologic).2 The most
common reaction reported in our study group was derma-
tologic, mainly being periorbital edema. Respiratory symp-
toms were signiﬁcantly more common in the asthmatic
group, whereas dermatological symptoms were frequent in
patients without asthma. This ﬁnding raises the question
that whether AI presenting with respiratory symptoms in
childhood could be a risk factor for developing asthma in the
following years.
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between 31% and 71% in various surveys,2,5,10 was 10% in our
patients. However, this result may be an underestimation of
the actual ﬁgure, as not all of our patients had an ENT
evaluation, which should ideally be done in every patient
with AI.
A family history of AI was more common in our study
population when compared with the previous reports in the
literature (34% vs 4.5–6%).8,11,12 This might be due to the
long follow up of patients who were reassessed in every
visit. The presence of a family history of atopy and asthma
were 20% and 24%, respectively. The differences between
the frequencies of familial history of each of these diseases
might implicate that AI, atopy and asthma are disorders with
different genetic basis.
Aspirin was the most common responsible agent for AI in
adults. Despite the reports showing paracetamol as the most
common consumed analgesic in Turkey,13 and less frequent
use of aspirin in pediatric age group after the demonstration
of its relationship with Reye’s syndrome, our study shows
that, aspirin is still the most common responsible agent
(68%) for AI in childhood. One of the basic characteristics of
AI is cross-reaction. Therefore, the patients in our cohort
reporting AI triggered by aspirin, are expected to develop
allergic reactions with other NSAIDs. However, a formal
challenge test with various NSAIDs has not been performed
in most of the cases. Physicians usually hesitate performing
OPT, especially in children, as a diagnostic test for AI
because of the possibility of life threatening reactions.
There is currently no in vitro test that has any diagnostic
value in AI, and OPT, nasal or inhalation challenge are still
the main tests recommended for the diagnosis of AI.14
In conclusion, AI which was once thought to be a disease
of adulthood, can have childhood onset and children may
have different sequence patterns of the disease. Despite
being a retrospective study and being confounded by recall
bias, with the diagnosis of AI depending on clinical history,
the study shows that AI in childhood may be a risk factor for
adult asthma. The pattern and pathophysiology of childhood
onset AI and its role in the development of bronchial asthma
must be evaluated in prospective, population-based epide-
miological studies.Conﬂict of interest statement
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